NovaGo Therapeutics focuses on two regeneration promoting therapeutics aimed at restoring nerve fibre connections in acute spinal cord injury(SCI) Ph1b clinical trial for SCI was started in Dec 2024 and successful finslaized. PoC studies planned to start mid 2026.
Member of the Swiss Biotech Association
Member
NovaGo Therapeutics AG
NovaGo Therapeutics AG
Verified listing
-
Founded2015
-
Employees in Switzerland1-9
- Website
- Send an email
- Get directions
- Bookmark
- Share
- Report
- prev
- next